Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

186.39
-3.4900-1.84%
Post-market: 186.05-0.3400-0.18%19:57 EDT
Volume:6.73M
Turnover:1.26B
Market Cap:329.24B
PE:79.66
High:190.67
Open:190.21
Low:185.01
Close:189.88
Loading ...

Abbvie Shares up 2.3% After Licensing Deal for Cancer Treatment With India's Glenmark Pharma Unit

THOMSON REUTERS
·
10 Jul

Ichnos Glenmark Innovation (Igi) and Abbvie Announce Exclusive Global Licensing Agreement for Isb 2001, a First-in-Class Cd38×Bcma×Cd3 Trispecific Antibody

THOMSON REUTERS
·
10 Jul

Abbvie Inc - Igi to Receive $700 Mln Upfront and $1.225 Bln in Milestones

THOMSON REUTERS
·
10 Jul

AbbVie (ABBV) Receives a Buy from Morgan Stanley

TIPRANKS
·
10 Jul

AbbVie in Immuno-Oncology Licensing Pact with IGI Therapeutics

Dow Jones
·
10 Jul

BRIEF-Glenmark Pharma Says Ichnos Glenmark Innovation (IGI), Abbvie Announce Exclusive Global Licensing Agreement

Reuters
·
10 Jul

AbbVie, Ichnos Glenmark Innovation enter exclusive licensing agreement

TIPRANKS
·
10 Jul

AbbVie Inc. Announces Exclusive Licensing Agreement and Phase 1 Clinical Trial for Pioneering ISB 2001 Trispecific Antibody in Multiple Myeloma Treatment

Reuters
·
10 Jul

Abbvie Inc - Igi to Receive $700 Mln Upfront and $1.225 Bln in Milestones

THOMSON REUTERS
·
10 Jul

Abbvie and Ichnos Glenmark Innovation (Igi) Announce Exclusive Global Licensing Agreement for Isb 2001, a First-in-Class Cd38×Bcma×Cd3 Trispecific Antibody

THOMSON REUTERS
·
10 Jul

Glenmark Pharma - Igi Will Receive an Upfront Payment of $700 Mln, Eligible to Receive up to $1.225 Bln

THOMSON REUTERS
·
10 Jul

AbbVie: A Strong Buy with Promising Growth Prospects and Stable Outlook

TIPRANKS
·
10 Jul

Morgan Stanley Maintained an Overweight Rating on AbbVie (ABBV)

Insider Monkey
·
09 Jul

AbbVie Buy Rating Supported by Strong Performance, Growth Prospects, and Strategic Positioning

TIPRANKS
·
09 Jul

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR)

TIPRANKS
·
09 Jul

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
09 Jul

Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy

Reuters
·
09 Jul

AbbVie’s New Study on ABBV-951: A Potential Game-Changer for Parkinson’s Disease Treatment

TIPRANKS
·
09 Jul

LVM Capital Management Loads Up on NOC, Buys 6,237 Shares in Q2 2025

Motley Fool
·
08 Jul

LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million

Motley Fool
·
08 Jul